Head-to-head · WeighScore
Fitstry vs ShapeIn Rx
The verdict
Fitstry takes it — 61.5/100 to 60.4/100, but only just.
Fitstry grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Fitstry is the GLP-1 weight-loss program of Weightstry, LLC, a LegitScript-certified, cash-pay telehealth practice focused on women 40+. ShapeIn Rx is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Fitstry | ShapeIn Rx |
|---|---|---|
| WeighScore | 61.5/100 | 60.4/100 |
| Grade | C | C |
| Scorecard rank | #292 | #323 |
| Semaglutide | $179/mo (annual plan, plus a separate fee, compounded) | $199/mo (compounded) |
| Tirzepatide | $269/mo (annual plan, compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #292 · C
Strengths
- Transparent pricing before you commit — compounded semaglutide from $179/mo, tirzepatide from $269/mo, oral GLP-1 from $209/mo (annual plan)
- Free screening with a one-time $99 program fee that is fully refunded if a clinician can't prescribe ('Approved, or Your $99 Back')
- Monthly price bundles a lab panel (CMP, A1c, lipids, TSH), unlimited clinician access, bi-weekly care coaching and a 24/7 Care Line
- Runs under Weightstry, LLC, a LegitScript-certified practice with an independently verifiable seal, a named support email and phone
- Full compounded lineup — weekly injection, daily oral tablet and microdosing options
Where it loses points
- Month-to-month pricing is notably higher than the annual plan ($249 vs $179 semaglutide, $339 vs $269 tirzepatide)
- Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
- Framed for women 40+, and serves 49 states rather than all 50 (the excluded state isn't disclosed publicly)
- Works with state-licensed compounding pharmacies but doesn't name a specific pharmacy partner on the Fitstry page
- Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Graded #323 · C
Strengths
- One of the few telehealth providers offering compounded liraglutide as a daily alternative to weekly injections
- Semaglutide is compounded with B12, and the combination is stated plainly
- Publishes a street address and a staffed phone line with hours
- States openly that telemedicine is limited to jurisdictions where its providers are licensed, rather than claiming all 50
- LegitScript certification verified against the issued seal, not just the badge
Where it loses points
- Advertises Trusted by 150k Americans and Excellent 4.8 with 150k happy customers, and neither figure is attributable to a verifiable review profile
- No state list is published, only a statement that coverage is limited and a note that partner pharmacies may operate in all 50 states
- The struck-through $199 next to $149 on the homepage reads as a discount but the two prices are different medications
- Claims No Hidden Fees and No Monthly Membership while the Terms state subscriptions automatically renew
- No compounding pharmacy is named, only US-Certified Pharmacy
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.